Hyperbaric oxygen induces late neuroplasticity in post stroke patients--randomized, prospective trial
Autor: | Olga Volkov, Shai Efrati, Nachum Gal, Eshel Ben-Jacob, Gregori Fishlev, Mony Friedman, Izhak Kamiager, Haim Golan, Yair Bechor, Jacob Bergan, Kostantin Kliakhandler |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2013 |
Předmět: |
Male
Anatomy and Physiology Critical Care and Emergency Medicine lcsh:Medicine Cardiovascular Biochemistry Diagnostic Radiology law.invention Randomized controlled trial Risk Factors law Molecular Cell Biology Neurobiology of Disease and Regeneration Activities of Daily Living Pathology lcsh:Science Stroke Neuropathology Neurons SPECT imaging Hyperbaric Oxygenation Neuronal Plasticity Multidisciplinary Neuromodulation Brain Neurochemistry Middle Aged Oxygen Metabolism Treatment Outcome Neurology Neurointensive Care Anesthesia Medicine Female Cellular Types medicine.symptom Radiology Research Article medicine.medical_specialty Clinical Research Design Cerebrovascular Diseases Neuroimaging Brain damage Neurological System Computed Tomography Hyperbaric oxygen Diagnostic Medicine Neurorehabilitation and Trauma Neuroplasticity medicine Humans Clinical Trials Biology Ischemic Stroke Aged Tomography Emission-Computed Single-Photon business.industry lcsh:R medicine.disease Clinical trial Neuroanatomy Metabolism Anatomical Pathology Prospective trial Nuclear medicine Quality of Life Physical therapy Post stroke lcsh:Q business Neuroscience |
Zdroj: | PLoS ONE, Vol 8, Iss 1, p e53716 (2013) PLoS ONE |
ISSN: | 1932-6203 |
Popis: | Background Recovery after stroke correlates with non-active (stunned) brain regions, which may persist for years. The current study aimed to evaluate whether increasing the level of dissolved oxygen by Hyperbaric Oxygen Therapy (HBOT) could activate neuroplasticity in patients with chronic neurologic deficiencies due to stroke. Methods and Findings A prospective, randomized, controlled trial including 74 patients (15 were excluded). All participants suffered a stroke 6–36 months prior to inclusion and had at least one motor dysfunction. After inclusion, patients were randomly assigned to "treated" or "cross" groups. Brain activity was assessed by SPECT imaging; neurologic functions were evaluated by NIHSS, ADL, and life quality. Patients in the treated group were evaluated twice: at baseline and after 40 HBOT sessions. Patients in the cross group were evaluated three times: at baseline, after a 2-month control period of no treatment, and after subsequent 2-months of 40 HBOT sessions. HBOT protocol: Two months of 40 sessions (5 days/week), 90 minutes each, 100% oxygen at 2 ATA. We found that the neurological functions and life quality of all patients in both groups were significantly improved following the HBOT sessions while no improvement was found during the control period of the patients in the cross group. Results of SPECT imaging were well correlated with clinical improvement. Elevated brain activity was detected mostly in regions of live cells (as confirmed by CT) with low activity (based on SPECT) – regions of noticeable discrepancy between anatomy and physiology. Conclusions The results indicate that HBOT can lead to significant neurological improvements in post stroke patients even at chronic late stages. The observed clinical improvements imply that neuroplasticity can still be activated long after damage onset in regions where there is a brain SPECT/CT (anatomy/physiology) mismatch. Trial Registration ClinicalTrials.gov NCT00715897 |
Databáze: | OpenAIRE |
Externí odkaz: |